Dublin, Dec. 02, 2019 (GLOBE NEWSWIRE) -- The "Market Spotlight: Cold Agglutinin Disease" report has been added to ResearchAndMarkets.com's offering.
This report covers the Cold Agglutinin Disease market, comprising disease background and treatment information, key pipeline drugs, clinical trials, probability of success, licensing and acquisition deals, and an epidemiology overview.
Key Takeaways
Key Topics Covered
OVERVIEW
KEY TAKEAWAYS
DISEASE BACKGROUND
Disease definition
Patient subtypes
Symptoms
Risk factors
Diagnosis
TREATMENT
Non-pharmacological treatment
Pharmacological treatment
EPIDEMIOLOGY
PIPELINE DRUGS
PROBABILITY OF SUCCESS
LICENSING AND ASSET ACQUISITION DEALS
PARENT PATENTS
CLINICAL TRIAL LANDSCAPE
Sponsors by status
Sponsors by phase
BIBLIOGRAPHY
APPENDIX
LIST OF FIGURES
Figure 1: Overview of pipeline drugs for cold agglutinin disease in the US
Figure 2: Pipeline drugs for cold agglutinin disease, by company
Figure 3: Pipeline drugs for cold agglutinin disease, by drug type
Figure 4: Pipeline drugs for cold agglutinin disease, by classification
Figure 5: Probability of success in the cold agglutinin disease pipeline
Figure 6: Licensing and asset acquisition deals in cold agglutinin disease, 2014-19
Figure 7: Clinical trials in cold agglutinin disease
Figure 8: Top 10 drugs for clinical trials in cold agglutinin disease
Figure 9: Top 10 companies for clinical trials in cold agglutinin disease
Figure 10: Cold agglutinin disease trials status
Figure 11: Cold agglutinin disease trials sponsors, by phase
LIST OF TABLES
Table 1: Pipeline drugs for cold agglutinin disease in the US
Table 2: Parent patents in cold agglutinin disease
For more information about this report visit https://www.researchandmarkets.com/r/fssy84
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.